Previous analyses of the uteroglobin gene promoter revealed a GT1 box which is also found in the SV40 enhancer. The GT1 element in the context of the uteroglobin promoter is active in Ishikawa cells, a human endometrial cell line, but not in HeLa cells. Here we report the cloning by recognition site screening of two factors (SPR-1 and SPR-2) which bind to this GT1 motif. SPR-1 and SPR-2 are homologues of the transcription factor Sp1. All three proteins are closely related members of a gene family encoding proteins with very similar structural features. Like Sp1, SPR-1 and SPR-2 contain glutamine and serine/threonine rich amino acid stretches. Most significantly, the DNA binding domains of all three proteins are highly conserved and they recognize GT as well as GC boxes identically. SPR-2 mRNA is expressed ubiquitously, whereas SPR-1 transcripts are abundant in the brain but barely detectable in other organs. The possible function of these factors for the activity of the uteroglobin promoter is discussed.
INTRODUCTION
The combinatorial action of transcription factors which bind to promoter and enhancer elements specifies the expression pattern of a gene in the organism. In the last few years, we have begun to explore the mechanisms responsible for the expression of the rabbit uteroglobin gene in certain ontogenetically unrelated epithelial cell types (mainly in endometrium and lung). We found that the uteroglobin promoter is utilized 10-fold more efficiently in the human endometrial cell line Ishikawa and in the lung cell line NCI-H441 than in HeLa cells or fibroblasts (1, 2) . Gene transfer experiments with 5'-promoter deletions and linker scanning promoter mutations as well as in vitro DNA binding studies with nuclear extracts identified several cis acting elements that are involved in promoter activity in Ishikawa cells. At least seven mutation-sensitive regions of the uteroglobin promoter contribute to its overall activity in this endometrial cell line (1,2) (Fig. 1) . One of these regions located 230 bp upstream of the transcription start site contains a sequence which is in 12 out of 13 nucleotides identical to the GT1 motif of the SV40 enhancer (3, 4, 5) . It also contains a so called CACCC box found in several other enhancers and promoters, including the tyrosine aminotransferase gene (6, 7) , the tryptophan oxygenase gene (8, 9) and the /3-globin gene (10) . The GT1/CACCC element in the context of the uteroglobin promoter is active in Ishikawa cells but not in HeLa cells (1) . Although some CACCC boxes are known to be recognized by Spl (11) , to date other factors that bind to these elements are not well characterized or cloned. To understand the molecular basis for the cell specificity of this element in the context of the uteroglobin promoter we have decided to clone the cDNA(s) of the protein(s) binding to the GT1 motif.
Here we report the cloning by recognition site screening of two novel factors which bind to the GT1 motif of the rabbit uteroglobin promoter. Both proteins are homologues of the transcription factor Spl. Therefore, we designate them Spl-related factors 1 and 2 (SPR-1 and SPR-2). All three proteins have similar structural domains and recognize GT and GC boxes with identical affinities. Northern blot analyses reveal that SPR-2 mRNA is expressed ubiquitously like Spl mRNA. In contrast, SPR-1 transcripts are abundant in brain but barely detectable in other organs.
MATERIALS AND METHODS

Construction of cDNA expression libraries and screening procedure
Two cDNA expression libraries in X gtll were constructed essentially as described (12, 13) using poly(A)-enriched RNA from Ishikawa cells (14) and commercially available random and oligo (dT) primers. For insertion of the cDNA into the EcoRI cloning site of X gtl 1 DNA a synthetic adapter containing a NotI site adjacent to an EcoRI site was used (15) . The random and oligo(dT) primed libraries contain 10 6 and 10 7 independent p.f.u., respectively. Ninety percent of the phages contain recombinant Xgtll DNA. Initially, the random primed library was screened according to Singh et al. (16) with the modifications of Vinson et al. (17) using concatemers of the 32 P-labeled double stranded oligonucleotide which has the sequence 5 '-ACCCCTTGCC AC ACCCCTGCACAAG-3'.
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Plasmid constructions
All \gtll phage cDNA inserts (see Fig. 2 A and C) were subcloned into the NotI site of the plasmid vector pBluescript II KS -(pKS) and sequenced by the chain termination method (18) using denatured double stranded DNA templates (19) . To express zinc finger containing fragments of SPR-1, SPR-2 and Spl in E.coli under the control of the T7 RNA polymerase dependent 010 promoter (20) , expression plasmids were constructed as follows. The plasmids for the expression of SPR-1 and SPR-2 were generated by inserting a 3 kb Smal fragment from plasmid pKS-A8O and a 0.8 kb blunted AccI-EcoRI fragment from pKS-A3O into the blunted BamHI sites of pET-3b and pET-3c, respectively. The Spl expression plasmid was constructed by cloning a blunted 4.4 kb Xbal fragment from the plasmid pBS-Spl-fl (kindly provided by Dr. R. Tjian) into the bluntrd BamHI site of pET-3c.
Ligation mediated PCR
The conditions for the synthesis of double stranded cDNA were essentially as described (12) using total RNA from Ishikawa cells (20 /tg) and a specific primer (5'-GAGTCCCTATTTTGCTGC-AAGTAGCTGCCAG-3') corresponding to nucleotides 332 to 362 of the SPR-1 cDNA shown in Fig. 2 B) . The cDNA synthesis products were purified by Sephadex G-50 chromatography and concentrated by lyophilization. A synthetic linker obtained by hybridization of the oligonucleotides 5'-GCGGTGACCCGGG-AGATCTGAATTC-3' (LMPCR1) and 5'-GAATTCAGATC-3' (LMPCR2) was ligated to the cDNA. For the amplification reaction the oligonucleotides 5'-GCCAGAGGAGAGGGCTG-AGAGTCCT-3' (corresponding to nucleotides 299 to 327 in Fig. 2 B) and LMPCR1 (see above) were used as primers. The ligation of the linker and the amplification of the cDNAs have been performed under conditions essentially as described (21, 22) . The PCR products were digested with Bglll (cuts in the linker) and Saul (site in the SPR-1 cDNA at position 292) and cloned into the BamHI/Saul sites of the plasmid pKS-A8O.
Expression in E.coli SPR-1, SPR-2 and Spl cDNA expression vectors (see above) were transformed into E.coli strain BL21(LysS) (20) . Cells were grown in LB medium to an ODgoo of 0.5 and expression was induced by adding isopropyl-/3-D-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. After 2 h at 37°C the bacteria were harvested and extracts prepared according to the procedure described for Spl (23) .
Gel retardation experiments
Gel retardations assays were essentially performed as described (24, 25) . For the competition experiments, bacterial extracts containing SPR-1, SPR-2 and Spl were mixed and gel retardation assays performed with oligonucleotides containing the GC box and GT box binding sites, respectively. The GC box binding site was obtained by hybridization of the oligonucleotides 5'-AGC-TTCCGTTGGGGCGGGGCTTCACG -3' and 5'-TCGACGTG-AAGCCCCGCCCCAACGGA-3'. The GT box binding site was obtained by hybridization of the oligonucleotides 5'-AGCTT-CCGTTGGGGTGTGGCTTCACG-3' and 5'-TCGACGTGAA-GCC AC ACCCC AACGG A-3'.
Northern blot analysis
Total RNA from human cell lines and mouse organs was extracted by the guanidinium isothiocyanate/CsCl procedure (26), separated on 1.2% agarose gels containing 2.2 M deionized formaldehyde and blotted to nylon membranes (Pall Biodyne B). Prehybridization and hybridization was carried out as described (27) using 32 P labeled cDNA fragments as probes. The specific activities of the probes were approximately 5 10 8 cpm//tg. Hybridization probes for SPR-1, SPR-2 and Spl mRNA were as follows. SPR-1: 0.8 kb Saul-Seal fragment (nucleotides 291 to 1115 in Fig. 2 B) or a 0.5 kb EcoRI fragment from pKS-A8O (containing nucleotides 2528 to 2971 shown in Fig. 2 B) . SPR-2: 0.4 kb Kpnl fragment from A3O (containing nucleotides 1270 to 1583 shown in Fig. 2 D) or a 180 bp EcoRV-NotI fragment frompKS-A3.1 (containing nucleotides 2169 to2349). Spl: 1.8 kb SstI fragment from plasmid pBS-Spl-fl (provided by Dr. Tjian). Control hybridizations of 18S ribosomal RNA have been performed as described (28) using a 32 P labeled single stranded oligonucleotide probe that has the sequence 5'-ACGGTATCTG-ATCGTCTTCG AACC-3'.
RESULTS
Cloning of proteins which bind to the GT1 motif
To identify the protein(s) of Ishikawa cells which bind(s) to the GT1 motif of the uteroglobin promoter ( Fig. 1 ) we decided to clone by recognition site screening their corresponding cDNA(s). Ishikawa cell cDNA expression libraries were generated by either random or oligo(dT) priming. The random primed library was screened for DNA binding proteins that recognize the GT1 motif. Initially, two cDNA clones of 2.8 kb (A8O) and 1 kb (A3O) in length have been obtained (Fig. 2 A and C) . Sequence analysis revealed that these cDNAs encode two different proteins, designated henceforth SPR-1 and SPR-2.
To obtain a more complete cDNA for SPR-2, both Ishikawa cDNA libraries were screened with subfragments of the A3O clone. Sequence comparison of the clones obtained by this screening procedure with the A3O clone shows that A3O differs at the 3' end from the corresponding nucleotide sequences of four other clones (A3.1, A3.11, A3.21 and A3.22). Northern blot analysis of RNA from Ishikawa cells with the 3' end of the A3O clone and the corresponding sequence of the A3.1 clone reveals that the latter but not the A3O-specific probe specifically hybridizes with RNA (data not shown). Therefore, we assume that the 3' end of A3O represents a cloning artifact generated during cDNA synthesis.
To obtain the complete open reading frame of SPR-1, ligation mediated PCR (21, 22) was employed using a SPR-1-specific primer that hybridizes 180 nucleotides downstream of the 5' end 
Structural features of SPR-1 and SPR-2
Inspection of the amino acid sequence, as deduced from the cDNA sequence, reveals that SPR-1 and SPR-2 have three zinc finger motifs of the Cys 2 /His 2 type near the C-terminus. These structural motifs were first identified as nine tandemly repeated sequences in the RNA polymerase in transcription factor TFIIIA (29, 30) and have been found later in many transcription factors from various species. The three zinc fingers of SPR-1 and SPR-2 are 90% identical to each other and to the zinc fingers of the transcription factor Spl originally isolated from HeLa cells (31) (Fig. 3 ). In addition, the amino acid sequences N-terminal of the zinc finger domain of SPR-1 and SPR-2 are also homologous to each other as well as to Spl (approximately 35% identity) and are composed of long serine/threonine-and glutamine-rich regions ( Fig. 3 A) which have been identified for Spl as transactivation domains (23, 32, 33) . Moreover, the amino acid sequences of SPR-1 and SPR-2 show 8 and 6 potential glycosylation sites (N-X-S/T), respectively, similar to the Spl amino acid sequence that has 10 potential glycosylation sites (31, 33) . Thus, it is likely that SPR-1 and SPR-2 are posttranslationally modified by glycosylation as it has been shown for Spl (34) .
DNA binding specificity
The high degree of conservation of the zinc finger regions of Spl, SPR-1 and SPR-2 ( Fig. 3 B) prompts the question whether all three proteins recognize the same DNA motifs with similar affinities. The structure of the Spl DNA binding domain itself is not known but the crystal structure of the protein-DNA complex of another DNA binding protein containing three zinc fingers of the Cys 2 /His 2 class, Zif268 (a mouse immediate early protein, also known as Krox-24) has been determined (35) . The three zinc fingers of Zif268 are related to Spl and bind the 9-base-pair target sequence 5'-GCGTGGGCG-3'. These structural data and in vitro directed mutagenesis guided by similarities between the zinc fingers of transcription factors Spl and Krox-20 (36) (Krox-20 has the same DNA binding domain as Krox-24) have identified amino acids governing DNA-binding specificity. All amino acids that are putatively involved in DNA recognition are fully conserved between Spl, SPR-1 and SPR-2. Therefore, it appears that Spl, SPR-1 and SPR-2 may recognize identical DNA sequences. To test this, we have subcloned zinc finger containing regions of Spl, SPR-1 and SPR-2 encoding 773, 263 and 778 C-terminal amino acids, respectively, in appropriate pET vectors (20) , expressed them in E.coli, and employed gel retardation assays using oligonucleotides containing the central part of the GT motif of the uteroglobin promoter (5'-GGGGTGT-GG-3') and a typical GC box (5'-GGGGCGGGG-3') (37) . Unique complexes are generated with SPR-1 and SPR-2 containing bacterial extracts using a 32 P labeled oligonucleotide containing the GT motif. Bacterially expressed full length Spl produces three different complexes. This phenomenon has already been observed previously (38) . Probably, the two faster migrating complexes are due to proteolytic degradation products of Spl or perhaps result from internal translation start sites. Nevertheless, all complexes are competed identically with excess amounts of unlabeled oligonucleotides containing either the GT or the GC motif (Fig. 4 A) but not with oligonucleotides containing a random sequence or with poly (dl-dC) (data not shown). Therefore, it appears that Spl, SPR-1 and SPR-2 bind the GT motif with identical affinities. In addition, the GC motif is recognized also identically by all three proteins but with an approximately 2-fold higher affinity than the GT box (Fig. 4 B) .
Expression in human cell lines and mouse organs
Northern blot analyses of total RNA from different human cell lines (Fig. 5 A) reveal that SPR-1 and SPR-2 mRNA are unique species of 7.5 kb and 5.0 kb. In comparison, Spl mRNA is 8.2 kb in length. Like Spl mRNA, SPR-2 mRNA is present in all cell lines tested and the relative amount of this mRNA differs only moderately. In contrast, SPR-1 mRNA concentration in these cell lines varies much more. It is highest in the two endometrial cell lines Ishikawa and MFE 296 and is not found in the lung epithelial cell line EPLC32M1.
To address the question how SPR-1 and SPR-2 mRNA levels vary in vivo, we performed Northern blot analyses with total RNA from mouse tissues using human SPR-1, SPR-2 and Spl cDNA probes outside the zinc finger encoding regions. Except for RNA from testis, all three cDNAs specifically hybridize to unique mRNA species from mouse organs (Fig. 5 B) . Spl and SPR-2 transcripts are present in all organs. The highest mRNA level is detectable in brain. Smaller SPR-2 and Spl transcripts appear exclusively in testis, suggesting that they arise from testis-specific processes. SPR-1 transcripts are abundantly present in brain but are barely detectable in other organs and tissues (salivary gland, liver, kidney, uterus, testis, seminal vesicle, lung, epididymis and esophagus). Quantitative evaluations (data not shown) show that the level of SPR-1 mRNA in brain is at least ten fold higher than in any other organ suggesting a brain-specific role of SPR-1.
DISCUSSION
We have previously identified elements of the uteroglobin promoter that contribute to its activity in the endometrial cell line Ishikawa. One of these elements is located 230 bp upstream of the transcriptional start site and contains a GT-rich motif that is also present in the SV40 enhancer. This element in the context of the uteroglobin promoter enhances transcription of a reporter gene in Ishikawa but not in HeLa cells (1) . Nevertheless, differences in the GT1 binding activity have not been detected between nuclear extracts from Ishikawa and HeLa cells (1 and unpublished results). One assumption to explain these results was that different proteins of similar size and binding properties might bind to this motif. The cloning by recognition site screening of SPR-1 and SPR-2 as members of a multigene family including Spl supports this idea. SPR-1 and Spl have calculated molecular weights of 81.9 kDa and 79. TCTGCTTTAI^CTAAAAATCAGAACATCTTCCTArrTATCTATTCTAAGATAAAAAACCTCgtCGCTGAAAGAAA  TCATGTTATCATAAAAAATrTTGTAATTTTCTrGATGACTCCAATrTrTATTATCCATAACTCACAAATCAAGTT  TCCAAGCAAATCrrACATAGTCTAGGCTTTACTrAGCTTATCAATTtCTCATTTTCAACCTAACTATrTTAATTA  CCTTAACTATCTACAATATTTTAACCATrACTCTTCTAAGATrrrCAAAACTACATTTTAACATGCAACTCTACC  CATAGTCACXTTTTAAATCCTCTTCAAAACCCATCrrrAACATTrAATTrCCCAAAATAATCTCTTCTTAATATT  CTTTCAATAACGAAGTT«aKMTATAACCAATCTTTAAAAAACTrrAAAATGTATAACTTCAGGCATTTCGCTC   2026  2101  2176  2251  2326  2401  2476  2551  2 62 6  2701  2776  2151  292S  3001  307(  3151  3226  3301  3376  3451  3526   TA   GCAGTGATTrTATCCAATCT^CTTTCCAAAAACCATGGTCTCCCACGGOrriAAAAGCCATCATCTAAATTACCA  CTAAACTt^AACATATGCAAACATAACAAAATCACTTCC»T«TCACCATACTCCAACCATATGCATATTAGTCA  TAGAAGAACTACAfflrrTTTATGATArrTrnTAAGTCTTrTTrTTTTGTCTAGGTAGTCACTCTGCACTTAAATA  TCAATCATTTraJTfTTfTCCTTCTTCCCTrAAAATTTATATGTATCCAGTACATTTAATTGAGAAQCGTATGTT  TTTTATTATtKrrGTATTrTCTTTTTATTTI^TAArrATTGTTrATATTTTCAATTCAAAAATC'tACAAAATAAftC  TTACATTGCTCGTCTOTCTAJUauarrATACACTTTTCCTAAATCTATACCTCrAACTtKJWKyurTTCAa  CCAAAAATTrGCAATTCTGTTCATTTGTTATTCTTAACACCACCTCAAfinT^AACGCTACCTTATrCTACCTTT  AAASTGTATfATAACAgfCTCCTACrrAATAAAACACTATTTrrrrrrCTTTWAAAAAAAAAAAAAAAAAAAAA  AAAAAAAAAAAAAAAAAAAAAAA finding that the GT1 motif of the uteroglobin promoter is active in Ishikawa cells but not in HeLa cells. One possibility is that SPR-1 and SPR-2 act in combination with other, endometriumspecific factors (see below). Alternatively, even more members of this new multigene family exist that are specifically expressed in Ishikawa cells. This is not unlikely as the recognition sit screening has not revealed clones for Spl, although Sp transcripts are present in Ishikawa cells in amounts comparabl to those for SPR-1 and SPR-2 mRNA.
SPR-2 and Spl transcripts are also abundant in uterus and lun and, therefore, may be involved in transcription of the uteroglobi gene in vivo. Unexpectedly, SPR-1 mRNA is abundant in brai but barely detectable in other organs. Nevertheless, this findin Binding sites for SPR-1, SPR-2 and Spl are present in many enhancers and promoters. Thus, it is very likely that the members of this new gene family are involved in the expression of many genes. All three proteins not only share their DNA binding domain with each other but also glutamine-rich regions which have been identified for Spl as transactivation domains (23) . Therefore, SPR-1 and SPR-2 probably also act as transactivators. But how might SPR-1, SPR-2 and Spl exert specific functions? It has been reported that stimulation of transcription by Spl may be dependent on the promoter context, as Spl sites placed upstream of some promoters do not allow Spl to function synergistically (40) . This raises the intriguing possibility that SPR-1, SPR-2 and Spl function promoter-specifically by interacting with different transcription factors. This issue cannot be easily clarified because our Northern blot analyses indicate that most cell lines contain all three proteins. The Drosophila SL2 cell line transcription system which has been used to characterize Spl may not be appropriate to address this question either, because other transcription factors that could be involved in the activity of a certain promoter might not be present in this cell line. In vitro transcription assays using nuclear extracts depleted of SPR-1, SPR-2 and Spl may have to be established to address these questions.
Spl can stimulate transcription synergistically from two or multiple binding sites (adjacent or far distant) in the Drosophila cell line SL2. For this synergistic action, the domain C-terminal to the zinc finger region (domain D of Spl) is required (40) . In contrast to other domains, the amino acid sequence of this domain is not conserved between Spl, SPR-1 and SPR-2. Thus, one could speculate that these parts of the proteins may play a crucial role for the combinatorial action with other transcription factors.
In conclusion, our results imply that the presence of GC or GT boxes in many promoters and enhancers does not necessarily mean that Spl is the sole transcription factor involved in expression of these genes. At least two other homologous factors, SPR-1 and SPR-2 that have highly conserved Spl-like zinc finger regions also bind to GT as well as GC boxes with identical affinities and very likely act as transcriptional regulators as well. It appears that like other control elements, such as API and CRE sites which bind families of transcription factors of at least six and seven members, respectively, (41, 42) , GT and GC boxes are also recognized by a family of factors. Therefore, the discovery of SPR-1 and SPR-2 introduces a new complexity in the combinatorial possibilities of transcriptional regulation exerted through GT and GC boxes. Functional investigations will be necessary to understand the interplay between Spl, SPR-1 and SPR-2. Further examination of the cellular and developmental specificity of the expression pattern of SPR-1, SPR-2 in comparison to Spl as well as gene disruption experiments with the corresponding mouse genes will also shed more light on the physiological role of these new proteins. 
